News | Mammography | July 30, 2018

FDA Approves New Tomosynthesis Quality Control Tests for ACR Digital Mammography QC Manual

Approval will help streamline digital breast tomosynthesis quality control procedures for mammography facilities

FDA Approves New Tomosynthesis Quality Control Tests for ACR Digital Mammography QC Manual

July 30, 2018 — The U.S. Food and Drug Administration (FDA) recently approved the American College of Radiology’s (ACR’s) amendment to the 2016 Alternative Standard #24 to the “Quality control tests--other modalities” requirement. This FDA review and approval of the ACR Digital Breast Tomosynthesis (DBT) quality control (QC) test procedures enables the college to incorporate DBT into the 2016 ACR Digital Mammography Quality Control Manual.

The FDA requires digital mammography facilities with DBT to perform QC for approved imaging systems, according to their respective manufacturers’ quality control manuals. Approval of this amendment will enable mammography QC technologists and medical physicists to use the updated ACR manual in lieu of manufacturers’ quality control manuals when it becomes available.

“The new DBT QC procedures in the updated ACR manual will promote uniformity of quality control since it will allow facilities to follow one manual, instead of the dozens of different manuals that are mandated for the varying manufacturers and models of digital mammography equipment with DBT,” said Eric Berns, Ph.D., lead author and chair of the ACR Subcommittee on Mammography Quality Assurance. “The new manual focuses on tests that are clinically relevant for high-quality imaging and provides the structure for a thorough and complete quality control program.”

The updated manual is currently undergoing preparation for publication and should be available in the fall of 2018. ACR-accredited mammography facilities (and those applying for accreditation) will be invited to download a free PDF of the manual. Medical physicists associated with ACR-accredited facilities may also obtain the link to the manual from their facility to download a free version.

The full amended FDA alternative standard approval can be viewed here.

For more information: www.acraccreditation.org

Related Content

The COVID-19 pandemic has impacted every facet of personal life, business operations and healthcare, including breast imaging and breast cancer care.

Getty Images

Feature | Breast Imaging | September 18, 2020 | By Susan Harvey, M.D.
The COVID-19 pandemic has impacted every facet o
UT Dallas study aims to advance thermography for monitoring tumors

Adolfo Lozano, PhD'20, works on a proof-of-concept computer model of the thermal properties of breast cancer. He and other UT Dallas researchers aim to improve digital thermal imaging as a tool for monitoring cancer and its treatment. Image courtesy of The University of Texas at Dallas

News | Breast Imaging | September 09, 2020
September 9, 2020 — ...
The solution leverages image transfer speed, tag morphing, and multi-vendor PACS capabilities to enable comprehensive image visualization and analysis at the point of care
News | Breast Imaging | September 03, 2020
September 3, 2020 — Based on its recent analysis of the global breast imaging workstation industry, Frost & Sulli
Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have compared the ability of three different artificial intelligence (AI) algorithms to identify breast cancer based on previously taken mammograms. The best algorithm proved to be as accurate as the average radiologist.
News | Breast Imaging | August 28, 2020
August 28, 2020 — Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have compared the
Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health, announced improvements to the Brevera Breast Biopsy System with CorLumina Imaging Technology, the world’s first and only breast biopsy solution to combine vacuum-assisted tissue acquisition, real-time imaging verification and advanced post-biopsy handling in one, integrated system.
News | Breast Biopsy Systems | August 28, 2020
August 28, 2020 — Hologic, Inc., an innovative medical technology company primarily focused on improving women’s heal
Single-dose radiotherapy replaces need for extra hospital visits, with benefits for patient safety and well-being

Getty Images

News | Women's Health | August 20, 2020
August 20, 2020— For most women with early breast cancer